Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
烽火通讯股价突破30元可能性分析
Type of publications
NITAG documentation (58)
Reports (3)
SAGE documentation (2)
Scientific publications (9)
Systematic reviews (SYSVAC) (374)
Regions
Africa (32)
Americas (30)
Eastern Mediterranean (3)
Europe (39)
South-East Asia (6)
Western Pacific (12)
Diseases
Cholera (1)
COVID-19 (193)
Dengue (3)
Diphtheria (4)
Haemophilus influenzae type B (5)
Hepatitis A (1)
Hepatitis B (19)
Herpes zoster (8)
HIV / AIDS (1)
Human papillomavirus (HPV) (35)
Influenza (52)
Japanese encephalitis (4)
Lyme disease, Borreliosis (1)
Measles (15)
Meningococcal disease (10)
Mpox (4)
Mumps (3)
Pertussis (8)
Pneumococcal disease (26)
Poliomyelitis (5)
Rotavirus (12)
RSV (Respiratory syncytial virus) (2)
Rubella (3)
Tetanus (8)
Tuberculosis (4)
Typhoid (5)
Varicella (5)
Yellow fever (3)
Show more
446 results found
2021
3rd update of the NITAG-BF recommendation on vaccination against COVID 19 in Burkina Faso - September 2021
2021
∙
JCVI
JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022 - 30 June 2021
2021
∙
NIAC
NIAC Recommendations on booster doses of COVID-19 vaccine for healthcare workers, 16-59 years with underlying conditions, and all those 50-59 years
2021
∙
Haut Conseil de la santé publique
Priority vaccination of the entourage of people immunocompromised against SARS-Cov 2 - 30 April, 2021
2021
∙
NACI
Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age
2021
∙
UNITAG
Recommendation report on prioritisation of risk groups in Uganda
2021
∙
STIKO
STIKO resolution on the 14th update of the COVID-19 vaccination recommendation
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2021
∙
NIAC
Updated recommendations regarding selection, dose and timing of booster doses of COVID-19 vaccine for those aged 60 years and over
2021
∙
JCVI
Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register